Choose a medicine and the chart shows the dose steps its US prescribing information lists, from the first dose onward, with the maintenance doses and the highest dose marked. It shows what each label says, never a dose for you. The prescriber decides the dose, and may keep a person on a step for longer or lower it.
Ozempic®
Semaglutide injection, once a week, for adults with type 2 diabetes.
Step on the label
Optional step
Maintenance dose
Ozempic®: the label's dose steps
Dose
When the label allows it
On the label
0.25 mg once a week
Weeks 1 to 4
Starting dose
0.5 mg once a week
From week 5
Maintenance dose
1 mg once a week
After at least 4 weeks on 0.5 mg (week 9 at the earliest)
Maintenance dose, Optional
2 mg once a week
After at least 4 weeks on 1 mg (week 13 at the earliest)
Maintenance dose, Optional, Highest dose
The label allows 1 mg, and then 2 mg, when more glycemic control is needed, each after at least 4 weeks on the dose before.
The prescriber decides the dose, and may keep a person on a step for longer or lower it.
Wegovy®
Semaglutide injection, once a week. The steps shown are for weight reduction in adults.
Step on the label
Maintenance dose
Wegovy®: the label's dose steps
Dose
When the label allows it
On the label
0.25 mg once a week
Weeks 1 to 4
Starting dose
0.5 mg once a week
Weeks 5 to 8
1 mg once a week
Weeks 9 to 12
1.7 mg once a week
Weeks 13 to 16
Maintenance dose
2.4 mg once a week
From week 17
Maintenance dose
7.2 mg once a week
After at least 4 weeks on 2.4 mg
Optional, Highest dose
For weight reduction in adults, the label's maintenance dose is 1.7 mg or 2.4 mg (recommended). It allows 7.2 mg (Wegovy® HD) for people who have tolerated 2.4 mg for at least 4 weeks when more weight reduction is clinically indicated.
The EU product information differs on 7.2 mg: only for adults with a BMI of 30 or more at the start of treatment, back to 2.4 mg if 7.2 mg brings no further weight improvement, and possibly given as three 2.4 mg injections. (EU product information, § 4.2)
The prescriber decides the dose, and may keep a person on a step for longer or lower it.
Wegovy® pill
Semaglutide tablet, once a day, from the same US label as Wegovy® injection.
Step on the label
Maintenance dose
Wegovy® pill: the label's dose steps
Dose
When the label allows it
On the label
1.5 mg once a day
Days 1 to 30
Starting dose
4 mg once a day
Days 31 to 60
9 mg once a day
Days 61 to 90
25 mg once a day
From day 91
Maintenance dose, Highest dose
The label's maintenance dose is 25 mg once a day, reached in steps of 30 days.
How the label says to take it: one tablet in the morning on an empty stomach, with up to 4 fl oz (118 mL) of water and no other liquid, swallowed whole. Then wait at least 30 minutes before eating, drinking or taking other oral medicines. No more than one tablet a day.
The EU product information differs: it uses steps of at least 4 weeks instead of 30 days, a fast of at least 8 hours before the tablet, up to 120 mL of water, and the same 30-minute wait. (EU product information, § 4.2)
The prescriber decides the dose, and may keep a person on a step for longer or lower it.
Mounjaro®
Tirzepatide injection, once a week, for type 2 diabetes. The steps shown are for adults.
Step on the label
Optional step
Mounjaro®: the label's dose steps
Dose
When the label allows it
On the label
2.5 mg once a week
From week 1
Starting dose
5 mg once a week
After at least 4 weeks on 2.5 mg (week 5 at the earliest)
Optional
7.5 mg once a week
After at least 4 weeks on 5 mg (week 9 at the earliest)
Optional
10 mg once a week
After at least 4 weeks on 7.5 mg (week 13 at the earliest)
Optional
12.5 mg once a week
After at least 4 weeks on 10 mg (week 17 at the earliest)
Optional
15 mg once a week
After at least 4 weeks on 12.5 mg (week 21 at the earliest)
Optional, Highest dose
The label raises the dose in 2.5 mg steps, after at least 4 weeks on the current dose, when more glycemic control is needed. Its maximum for adults is 15 mg.
The EU product information differs: it raises 2.5 mg to 5 mg after 4 weeks and names 5 mg, 10 mg and 15 mg as the maintenance doses. (EU product information, § 4.2)
The prescriber decides the dose, and may keep a person on a step for longer or lower it.
Zepbound®: weight
Tirzepatide injection, once a week, for weight reduction and long-term maintenance.
Step on the label
Optional step
Maintenance dose
Zepbound®: weight: the label's dose steps
Dose
When the label allows it
On the label
2.5 mg once a week
Weeks 1 to 4
Starting dose
5 mg once a week
From week 5
Maintenance dose
7.5 mg once a week
After at least 4 weeks on 5 mg (week 9 at the earliest)
Optional
10 mg once a week
After at least 4 weeks on 7.5 mg (week 13 at the earliest)
Maintenance dose, Optional
12.5 mg once a week
After at least 4 weeks on 10 mg (week 17 at the earliest)
Optional
15 mg once a week
After at least 4 weeks on 12.5 mg (week 21 at the earliest)
Maintenance dose, Optional, Highest dose
The label calls 2.5 mg a starting dose that is not approved for maintenance. After 5 mg, it allows 2.5 mg steps, each after at least 4 weeks on the current dose. Its maintenance dose is 5 mg, 10 mg or 15 mg.
The prescriber decides the dose, and may keep a person on a step for longer or lower it.
Foundayo®
Orforglipron tablet, once a day.
Step on the label
Optional step
Foundayo®: the label's dose steps
Dose
When the label allows it
On the label
0.8 mg once a day
From day 1
Starting dose
2.5 mg once a day
After at least 30 days on 0.8 mg (day 31 at the earliest)
5.5 mg once a day
After at least 30 days on 2.5 mg (day 61 at the earliest)
9 mg once a day
After at least 30 days on 5.5 mg (day 91 at the earliest)
Optional
14.5 mg once a day
After at least 30 days on 9 mg (day 121 at the earliest)
Optional
17.2 mg once a day
After at least 30 days on 14.5 mg (day 151 at the earliest)
Optional, Highest dose
After 5.5 mg, the label allows 9 mg, 14.5 mg and 17.2 mg, each after at least 30 days on the current dose, based on treatment response and tolerability.
How the label says to take it: with or without food, swallowed whole, no more than one tablet a day. With a strong CYP3A4 inhibitor, the label's maximum is 9 mg.
Foundayo® is not yet authorised in the EU. The EMA's committee (CHMP) gave a positive opinion in October 2026. (EU product information)
The prescriber decides the dose, and may keep a person on a step for longer or lower it.
How do you read a label's dose schedule?
Most GLP-1 labels start with a low dose and raise it in steps. The chart puts time on the bottom, counted from week 1 (or day 1), the week of the first dose, and the dose in mg up the side.
A solid line is a step the label always lists.
A dashed line is an optional step: the label allows it but does not require it.
A colored line with a dot is a maintenance dose, one the label intends people to stay on.
The line marked "highest dose" is the top of the label's schedule.
Where a label says "after at least 4 weeks", the table gives the earliest week that allows. It is a minimum, not a date to aim for. This is how the labels compare at a glance:
How do you read a label's dose schedule?
Medicine
Starting dose
First step lasts
Maintenance on the label
Highest dose
Ozempic®
0.25 mg weekly
4 weeks
0.5, 1 or 2 mg
2 mg
Wegovy®
0.25 mg weekly
4 weeks
1.7 or 2.4 mg
7.2 mg
Wegovy® pill
1.5 mg daily
30 days
25 mg
25 mg
Mounjaro®
2.5 mg weekly
At least 4 weeks
Raised only if more glycemic control is needed
15 mg
Zepbound®, weight
2.5 mg weekly
4 weeks
5, 10 or 15 mg
15 mg
Zepbound®, sleep apnea
2.5 mg weekly
4 weeks
10 or 15 mg
15 mg
Foundayo®
0.8 mg daily
At least 30 days
Raised past the third step on response and tolerability
17.2 mg
Saxenda®
0.6 mg daily
1 week
3 mg
3 mg
The doses are in mg of different medicines, so a bigger number on one row does not mean a stronger treatment than on another.
Why are the steps 4 weeks apart?
The weekly injections step up every 4 weeks, or after at least 4 weeks. The EU product information for Wegovy gives the reason for going slowly: the dose is escalated over 16 weeks "To reduce the likelihood of gastrointestinal symptoms". The US Wegovy label adds that if a dose is not tolerated during escalation, the next step can be delayed by 4 weeks.
On the Wegovy table, 2.4 mg starts at week 17: four 4-week steps of 0.25, 0.5, 1 and 1.7 mg come first. Zepbound reaches 15 mg at week 21 at the earliest, after five steps.
The tablets count in days. The Wegovy pill steps every 30 days and reaches 25 mg on day 91. Foundayo allows each step after at least 30 days, so 17.2 mg comes on day 151 at the earliest. Saxenda is a daily injection with weekly steps: 0.6 mg in week 1, then 0.6 mg more each week, reaching 3 mg in week 5.
What does a maintenance dose mean?
A maintenance dose is a dose the label expects people to stay on, once the steps before it are done. Lower doses exist to start treatment. The Zepbound label is explicit: "The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage." The Saxenda label says the same of its lower doses: they "are for titration only".
Several labels list more than one maintenance dose. Wegovy names 1.7 mg or 2.4 mg (recommended) for weight reduction, and Ozempic names 0.5, 1 or 2 mg, depending on glycemic control. Which one applies is the prescriber's call.
What can the chart not tell you?
Your own schedule. Labels allow a step to be delayed when a dose is not tolerated, and a prescriber may keep a person on a step for longer or choose a lower dose.
Any dates. The chart has no start date and no calendar. For a missed or late dose, the label and the prescriber are the guide.
A comparison of medicines. The labels cover different conditions and different people. The chart puts their schedules side by side and leaves the choice to the reader and their prescriber.
Compounded products. They are not the approved medicines, and these label schedules do not describe them.
Schedules for children. The chart shows the adult steps. Some labels have separate rules for children or teenagers.
What does the EU product information say differently?
Wegovy 7.2 mg: in the EU only for adults with a BMI of 30 or more at the start of treatment, back to 2.4 mg if 7.2 mg brings no further benefit, and it can be given as three 2.4 mg injections.
Wegovy pill: steps of at least 4 weeks instead of 30 days, a fast of at least 8 hours, up to 120 mL of water and the same 30-minute wait.
Mounjaro: 2.5 mg is raised to 5 mg after 4 weeks, and 5, 10 and 15 mg are named as maintenance doses.
Foundayo: not yet authorised in the EU; the EMA's committee gave a positive opinion in October 2026.
Frequently asked questions
What is the highest dose of Wegovy?
7.2 mg once weekly (Wegovy® HD), for weight reduction in adults, after at least 4 weeks on 2.4 mg when more weight reduction is clinically indicated. The usual maintenance dose is 2.4 mg. The Wegovy dose chart has the full schedule.
How long does it take to reach the Zepbound maintenance dose?
5 mg, the first maintenance dose for weight reduction, starts at week 5. On the label's 2.5 mg steps, 10 mg can start at week 13 at the earliest and 15 mg at week 21. The Zepbound dose chart shows both indications.
Why does the Wegovy pill count in days?
Its label titrates "every 30 days", not every 4 weeks, so the chart counts days for it. The same is true of Foundayo.
How long does each dose stay in the body?
The GLP-1 half-life calculator estimates how much semaglutide, tirzepatide or liraglutide your doses may leave, from each label's half-life.